nodes	percent_of_prediction	percent_of_DWPC	metapath
Micafungin—COMT—Estrogen metabolism—GSTA1—liver cancer	0.0177	0.069	CbGpPWpGaD
Micafungin—ARSA—Post-translational protein modification—ADAMTS17—liver cancer	0.0115	0.0449	CbGpPWpGaD
Micafungin—ARSA—PTM: gamma carboxylation, hypusine formation and arylsulfatase activation—F2—liver cancer	0.0112	0.0437	CbGpPWpGaD
Micafungin—COMT—Phase II conjugation—UGDH—liver cancer	0.0101	0.0392	CbGpPWpGaD
Micafungin—COMT—Estrogen metabolism—GSTM1—liver cancer	0.00863	0.0337	CbGpPWpGaD
Micafungin—COMT—Estrogen metabolism—CYP1A1—liver cancer	0.00818	0.0319	CbGpPWpGaD
Micafungin—COMT—Biological oxidations—UGDH—liver cancer	0.00588	0.0229	CbGpPWpGaD
Micafungin—COMT—Phase II conjugation—GSTA3—liver cancer	0.00577	0.0225	CbGpPWpGaD
Micafungin—ARSA—Metabolism of proteins—ADAMTS17—liver cancer	0.00546	0.0213	CbGpPWpGaD
Micafungin—COMT—Phase II conjugation—GSTA4—liver cancer	0.00528	0.0206	CbGpPWpGaD
Micafungin—COMT—Phase II conjugation—GSTA2—liver cancer	0.00515	0.0201	CbGpPWpGaD
Micafungin—ARSA—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.00506	0.0197	CbGpPWpGaD
Micafungin—COMT—Phase II conjugation—GSTA1—liver cancer	0.00496	0.0194	CbGpPWpGaD
Micafungin—COMT—Phase II conjugation—NAT2—liver cancer	0.00491	0.0192	CbGpPWpGaD
Micafungin—ARSA—Metabolism of proteins—YIF1A—liver cancer	0.00414	0.0162	CbGpPWpGaD
Micafungin—COMT—Phase II conjugation—HPGDS—liver cancer	0.00392	0.0153	CbGpPWpGaD
Micafungin—COMT—Biological oxidations—NR1H4—liver cancer	0.00344	0.0134	CbGpPWpGaD
Micafungin—ARSA—Metabolism of proteins—EXOSC2—liver cancer	0.00341	0.0133	CbGpPWpGaD
Micafungin—COMT—Biological oxidations—GSTA3—liver cancer	0.00338	0.0132	CbGpPWpGaD
Micafungin—COMT—Metapathway biotransformation—GSTA3—liver cancer	0.00333	0.013	CbGpPWpGaD
Micafungin—ARSA—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.00326	0.0127	CbGpPWpGaD
Micafungin—COMT—Transmission across Chemical Synapses—GLUL—liver cancer	0.00316	0.0123	CbGpPWpGaD
Micafungin—ARSA—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.00314	0.0123	CbGpPWpGaD
Micafungin—COMT—Biological oxidations—GSTA4—liver cancer	0.00309	0.0121	CbGpPWpGaD
Micafungin—COMT—Metapathway biotransformation—GSTA4—liver cancer	0.00305	0.0119	CbGpPWpGaD
Micafungin—COMT—Biological oxidations—GSTA2—liver cancer	0.00301	0.0117	CbGpPWpGaD
Micafungin—COMT—Phase II conjugation—GGT1—liver cancer	0.00294	0.0115	CbGpPWpGaD
Micafungin—COMT—Biological oxidations—GSTA1—liver cancer	0.0029	0.0113	CbGpPWpGaD
Micafungin—COMT—Biological oxidations—NAT2—liver cancer	0.00287	0.0112	CbGpPWpGaD
Micafungin—COMT—Metapathway biotransformation—NAT2—liver cancer	0.00283	0.0111	CbGpPWpGaD
Micafungin—COMT—Phase II conjugation—GSTP1—liver cancer	0.00264	0.0103	CbGpPWpGaD
Micafungin—Delirium—Doxorubicin—liver cancer	0.00263	0.00354	CcSEcCtD
Micafungin—Leukopenia—Sorafenib—liver cancer	0.00259	0.00348	CcSEcCtD
Micafungin—Blood bilirubin increased—Epirubicin—liver cancer	0.00259	0.00348	CcSEcCtD
Micafungin—Cough—Sorafenib—liver cancer	0.00253	0.0034	CcSEcCtD
Micafungin—Inflammation—Epirubicin—liver cancer	0.00252	0.00339	CcSEcCtD
Micafungin—Bone disorder—Doxorubicin—liver cancer	0.00251	0.00337	CcSEcCtD
Micafungin—Hypertension—Sorafenib—liver cancer	0.0025	0.00336	CcSEcCtD
Micafungin—Hyperbilirubinaemia—Doxorubicin—liver cancer	0.00249	0.00335	CcSEcCtD
Micafungin—Hypocalcaemia—Doxorubicin—liver cancer	0.00247	0.00333	CcSEcCtD
Micafungin—Arthralgia—Sorafenib—liver cancer	0.00246	0.00331	CcSEcCtD
Micafungin—Oliguria—Doxorubicin—liver cancer	0.00246	0.0033	CcSEcCtD
Micafungin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00245	0.00329	CcSEcCtD
Micafungin—Hiccups—Epirubicin—liver cancer	0.00245	0.00329	CcSEcCtD
Micafungin—Pulmonary embolism—Epirubicin—liver cancer	0.00245	0.00329	CcSEcCtD
Micafungin—Hepatocellular injury—Epirubicin—liver cancer	0.00245	0.00329	CcSEcCtD
Micafungin—Injection site reaction—Epirubicin—liver cancer	0.00243	0.00327	CcSEcCtD
Micafungin—COMT—Phase II conjugation—GSTM1—liver cancer	0.00242	0.00946	CbGpPWpGaD
Micafungin—COMT—Neuronal System—GLUL—liver cancer	0.00242	0.00944	CbGpPWpGaD
Micafungin—COMT—Metapathway biotransformation—GPX3—liver cancer	0.00241	0.0094	CbGpPWpGaD
Micafungin—Hyperkalaemia—Epirubicin—liver cancer	0.0024	0.00323	CcSEcCtD
Micafungin—ARSA—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.0024	0.00937	CbGpPWpGaD
Micafungin—ARSA—Metabolism—UGDH—liver cancer	0.00239	0.00935	CbGpPWpGaD
Micafungin—Blood bilirubin increased—Doxorubicin—liver cancer	0.00239	0.00322	CcSEcCtD
Micafungin—Anaphylactic shock—Sorafenib—liver cancer	0.00236	0.00318	CcSEcCtD
Micafungin—Infection—Sorafenib—liver cancer	0.00235	0.00316	CcSEcCtD
Micafungin—Skin exfoliation—Epirubicin—liver cancer	0.00234	0.00314	CcSEcCtD
Micafungin—Inflammation—Doxorubicin—liver cancer	0.00233	0.00314	CcSEcCtD
Micafungin—Shock—Sorafenib—liver cancer	0.00232	0.00312	CcSEcCtD
Micafungin—Fluid retention—Epirubicin—liver cancer	0.00232	0.00312	CcSEcCtD
Micafungin—Nervous system disorder—Sorafenib—liver cancer	0.00232	0.00311	CcSEcCtD
Micafungin—Thrombocytopenia—Sorafenib—liver cancer	0.00231	0.00311	CcSEcCtD
Micafungin—Blood urea increased—Epirubicin—liver cancer	0.00231	0.00311	CcSEcCtD
Micafungin—COMT—Biological oxidations—HPGDS—liver cancer	0.0023	0.00896	CbGpPWpGaD
Micafungin—Skin disorder—Sorafenib—liver cancer	0.00229	0.00309	CcSEcCtD
Micafungin—Hepatocellular injury—Doxorubicin—liver cancer	0.00226	0.00304	CcSEcCtD
Micafungin—Pulmonary embolism—Doxorubicin—liver cancer	0.00226	0.00304	CcSEcCtD
Micafungin—Hiccups—Doxorubicin—liver cancer	0.00226	0.00304	CcSEcCtD
Micafungin—Anorexia—Sorafenib—liver cancer	0.00225	0.00303	CcSEcCtD
Micafungin—ARSA—Metabolism—EPT1—liver cancer	0.00225	0.00879	CbGpPWpGaD
Micafungin—Injection site reaction—Doxorubicin—liver cancer	0.00225	0.00303	CcSEcCtD
Micafungin—Hyperkalaemia—Doxorubicin—liver cancer	0.00222	0.00299	CcSEcCtD
Micafungin—Skin exfoliation—Doxorubicin—liver cancer	0.00216	0.00291	CcSEcCtD
Micafungin—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00215	0.00289	CcSEcCtD
Micafungin—Fluid retention—Doxorubicin—liver cancer	0.00215	0.00289	CcSEcCtD
Micafungin—Blood urea increased—Doxorubicin—liver cancer	0.00214	0.00287	CcSEcCtD
Micafungin—ARSA—Metabolism—TAT—liver cancer	0.00213	0.00833	CbGpPWpGaD
Micafungin—Sepsis—Epirubicin—liver cancer	0.00212	0.00286	CcSEcCtD
Micafungin—Dyspnoea—Sorafenib—liver cancer	0.00211	0.00283	CcSEcCtD
Micafungin—ARSA—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.0021	0.00819	CbGpPWpGaD
Micafungin—Dyspepsia—Sorafenib—liver cancer	0.00208	0.0028	CcSEcCtD
Micafungin—Phlebitis—Epirubicin—liver cancer	0.00206	0.00277	CcSEcCtD
Micafungin—Decreased appetite—Sorafenib—liver cancer	0.00205	0.00276	CcSEcCtD
Micafungin—Thrombophlebitis—Epirubicin—liver cancer	0.00205	0.00276	CcSEcCtD
Micafungin—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.00204	0.00275	CcSEcCtD
Micafungin—Gastrointestinal disorder—Sorafenib—liver cancer	0.00204	0.00274	CcSEcCtD
Micafungin—Fatigue—Sorafenib—liver cancer	0.00204	0.00274	CcSEcCtD
Micafungin—Hepatic function abnormal—Epirubicin—liver cancer	0.00203	0.00273	CcSEcCtD
Micafungin—Constipation—Sorafenib—liver cancer	0.00202	0.00272	CcSEcCtD
Micafungin—Hepatic failure—Epirubicin—liver cancer	0.00198	0.00266	CcSEcCtD
Micafungin—Sepsis—Doxorubicin—liver cancer	0.00196	0.00264	CcSEcCtD
Micafungin—Gastrointestinal pain—Sorafenib—liver cancer	0.00193	0.0026	CcSEcCtD
Micafungin—Renal failure acute—Epirubicin—liver cancer	0.00192	0.00259	CcSEcCtD
Micafungin—ARSA—Metabolism of proteins—ATF3—liver cancer	0.00192	0.00747	CbGpPWpGaD
Micafungin—Phlebitis—Doxorubicin—liver cancer	0.00191	0.00257	CcSEcCtD
Micafungin—Thrombophlebitis—Doxorubicin—liver cancer	0.0019	0.00255	CcSEcCtD
Micafungin—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.00189	0.00254	CcSEcCtD
Micafungin—Hepatic function abnormal—Doxorubicin—liver cancer	0.00188	0.00253	CcSEcCtD
Micafungin—Urticaria—Sorafenib—liver cancer	0.00188	0.00252	CcSEcCtD
Micafungin—COMT—Biological oxidations—CYP2E1—liver cancer	0.00187	0.0073	CbGpPWpGaD
Micafungin—Abdominal pain—Sorafenib—liver cancer	0.00187	0.00251	CcSEcCtD
Micafungin—Body temperature increased—Sorafenib—liver cancer	0.00187	0.00251	CcSEcCtD
Micafungin—Renal impairment—Epirubicin—liver cancer	0.00187	0.00251	CcSEcCtD
Micafungin—COMT—Metapathway biotransformation—CYP2E1—liver cancer	0.00185	0.0072	CbGpPWpGaD
Micafungin—Anaphylactoid reaction—Epirubicin—liver cancer	0.00184	0.00247	CcSEcCtD
Micafungin—ARSA—Post-translational protein modification—F2—liver cancer	0.00183	0.00715	CbGpPWpGaD
Micafungin—Hepatic failure—Doxorubicin—liver cancer	0.00183	0.00246	CcSEcCtD
Micafungin—Hypoglycaemia—Epirubicin—liver cancer	0.00182	0.00245	CcSEcCtD
Micafungin—Hyponatraemia—Epirubicin—liver cancer	0.00178	0.0024	CcSEcCtD
Micafungin—Renal failure acute—Doxorubicin—liver cancer	0.00178	0.00239	CcSEcCtD
Micafungin—Hypersensitivity—Sorafenib—liver cancer	0.00174	0.00234	CcSEcCtD
Micafungin—Renal impairment—Doxorubicin—liver cancer	0.00173	0.00232	CcSEcCtD
Micafungin—COMT—Biological oxidations—GGT1—liver cancer	0.00172	0.00671	CbGpPWpGaD
Micafungin—Anaphylactoid reaction—Doxorubicin—liver cancer	0.0017	0.00228	CcSEcCtD
Micafungin—Asthenia—Sorafenib—liver cancer	0.00169	0.00228	CcSEcCtD
Micafungin—Cardiac arrest—Epirubicin—liver cancer	0.00169	0.00227	CcSEcCtD
Micafungin—Hypoglycaemia—Doxorubicin—liver cancer	0.00168	0.00226	CcSEcCtD
Micafungin—Pruritus—Sorafenib—liver cancer	0.00167	0.00225	CcSEcCtD
Micafungin—Blood creatinine increased—Epirubicin—liver cancer	0.00166	0.00224	CcSEcCtD
Micafungin—Hyponatraemia—Doxorubicin—liver cancer	0.00165	0.00222	CcSEcCtD
Micafungin—Liver function test abnormal—Epirubicin—liver cancer	0.00164	0.0022	CcSEcCtD
Micafungin—Abdominal pain upper—Epirubicin—liver cancer	0.00162	0.00218	CcSEcCtD
Micafungin—Hypokalaemia—Epirubicin—liver cancer	0.00162	0.00217	CcSEcCtD
Micafungin—Diarrhoea—Sorafenib—liver cancer	0.00162	0.00217	CcSEcCtD
Micafungin—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.0016	0.00215	CcSEcCtD
Micafungin—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.0016	0.00215	CcSEcCtD
Micafungin—ARSA—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.00157	0.00613	CbGpPWpGaD
Micafungin—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00157	0.00211	CcSEcCtD
Micafungin—Cardiac arrest—Doxorubicin—liver cancer	0.00156	0.0021	CcSEcCtD
Micafungin—Dizziness—Sorafenib—liver cancer	0.00156	0.0021	CcSEcCtD
Micafungin—Abdominal distension—Epirubicin—liver cancer	0.00155	0.00208	CcSEcCtD
Micafungin—COMT—Biological oxidations—GSTP1—liver cancer	0.00154	0.00602	CbGpPWpGaD
Micafungin—Blood creatinine increased—Doxorubicin—liver cancer	0.00154	0.00207	CcSEcCtD
Micafungin—COMT—Metapathway biotransformation—GSTP1—liver cancer	0.00152	0.00594	CbGpPWpGaD
Micafungin—Eosinophilia—Epirubicin—liver cancer	0.00152	0.00204	CcSEcCtD
Micafungin—Liver function test abnormal—Doxorubicin—liver cancer	0.00152	0.00204	CcSEcCtD
Micafungin—Vomiting—Sorafenib—liver cancer	0.0015	0.00202	CcSEcCtD
Micafungin—Abdominal pain upper—Doxorubicin—liver cancer	0.0015	0.00202	CcSEcCtD
Micafungin—Hypokalaemia—Doxorubicin—liver cancer	0.0015	0.00201	CcSEcCtD
Micafungin—Rash—Sorafenib—liver cancer	0.00149	0.002	CcSEcCtD
Micafungin—Dermatitis—Sorafenib—liver cancer	0.00149	0.002	CcSEcCtD
Micafungin—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00148	0.00199	CcSEcCtD
Micafungin—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00148	0.00199	CcSEcCtD
Micafungin—Headache—Sorafenib—liver cancer	0.00148	0.00199	CcSEcCtD
Micafungin—Pancytopenia—Epirubicin—liver cancer	0.00146	0.00196	CcSEcCtD
Micafungin—ARSA—Metabolism—CPT1B—liver cancer	0.00145	0.00566	CbGpPWpGaD
Micafungin—ARSA—Metabolism—GLUL—liver cancer	0.00145	0.00566	CbGpPWpGaD
Micafungin—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00145	0.00195	CcSEcCtD
Micafungin—Neutropenia—Epirubicin—liver cancer	0.00144	0.00193	CcSEcCtD
Micafungin—Abdominal distension—Doxorubicin—liver cancer	0.00143	0.00192	CcSEcCtD
Micafungin—COMT—Biological oxidations—GSTM1—liver cancer	0.00142	0.00554	CbGpPWpGaD
Micafungin—Eosinophilia—Doxorubicin—liver cancer	0.00141	0.00189	CcSEcCtD
Micafungin—Nausea—Sorafenib—liver cancer	0.0014	0.00189	CcSEcCtD
Micafungin—ARSA—Metabolism—NR1H4—liver cancer	0.0014	0.00546	CbGpPWpGaD
Micafungin—COMT—Metapathway biotransformation—GSTM1—liver cancer	0.0014	0.00546	CbGpPWpGaD
Micafungin—Hyperglycaemia—Epirubicin—liver cancer	0.00138	0.00186	CcSEcCtD
Micafungin—Pneumonia—Epirubicin—liver cancer	0.00138	0.00185	CcSEcCtD
Micafungin—ARSA—Metabolism—GSTA3—liver cancer	0.00138	0.00537	CbGpPWpGaD
Micafungin—Infestation NOS—Epirubicin—liver cancer	0.00137	0.00184	CcSEcCtD
Micafungin—Infestation—Epirubicin—liver cancer	0.00137	0.00184	CcSEcCtD
Micafungin—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00136	0.00182	CcSEcCtD
Micafungin—Pancytopenia—Doxorubicin—liver cancer	0.00135	0.00181	CcSEcCtD
Micafungin—Renal failure—Epirubicin—liver cancer	0.00135	0.00181	CcSEcCtD
Micafungin—COMT—Biological oxidations—CYP1A1—liver cancer	0.00134	0.00525	CbGpPWpGaD
Micafungin—Jaundice—Epirubicin—liver cancer	0.00133	0.00179	CcSEcCtD
Micafungin—Neutropenia—Doxorubicin—liver cancer	0.00133	0.00179	CcSEcCtD
Micafungin—COMT—Metapathway biotransformation—CYP1A1—liver cancer	0.00133	0.00518	CbGpPWpGaD
Micafungin—Haematuria—Epirubicin—liver cancer	0.00131	0.00175	CcSEcCtD
Micafungin—Hepatobiliary disease—Epirubicin—liver cancer	0.00129	0.00174	CcSEcCtD
Micafungin—Epistaxis—Epirubicin—liver cancer	0.00129	0.00174	CcSEcCtD
Micafungin—Hyperglycaemia—Doxorubicin—liver cancer	0.00128	0.00172	CcSEcCtD
Micafungin—Pneumonia—Doxorubicin—liver cancer	0.00127	0.00171	CcSEcCtD
Micafungin—Infestation—Doxorubicin—liver cancer	0.00127	0.0017	CcSEcCtD
Micafungin—Infestation NOS—Doxorubicin—liver cancer	0.00127	0.0017	CcSEcCtD
Micafungin—ARSA—Metabolism—GSTA4—liver cancer	0.00126	0.00491	CbGpPWpGaD
Micafungin—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00126	0.00169	CcSEcCtD
Micafungin—Bradycardia—Epirubicin—liver cancer	0.00125	0.00168	CcSEcCtD
Micafungin—Renal failure—Doxorubicin—liver cancer	0.00125	0.00167	CcSEcCtD
Micafungin—Jaundice—Doxorubicin—liver cancer	0.00123	0.00166	CcSEcCtD
Micafungin—ARSA—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.00123	0.0048	CbGpPWpGaD
Micafungin—Hepatitis—Epirubicin—liver cancer	0.00123	0.00165	CcSEcCtD
Micafungin—ARSA—Metabolism—GSTA2—liver cancer	0.00123	0.00478	CbGpPWpGaD
Micafungin—Urinary tract disorder—Epirubicin—liver cancer	0.00121	0.00163	CcSEcCtD
Micafungin—Oedema peripheral—Epirubicin—liver cancer	0.00121	0.00163	CcSEcCtD
Micafungin—Haematuria—Doxorubicin—liver cancer	0.00121	0.00162	CcSEcCtD
Micafungin—Connective tissue disorder—Epirubicin—liver cancer	0.00121	0.00162	CcSEcCtD
Micafungin—Urethral disorder—Epirubicin—liver cancer	0.0012	0.00162	CcSEcCtD
Micafungin—Hepatobiliary disease—Doxorubicin—liver cancer	0.0012	0.00161	CcSEcCtD
Micafungin—Epistaxis—Doxorubicin—liver cancer	0.00119	0.00161	CcSEcCtD
Micafungin—ARSA—Metabolism of proteins—IGF2—liver cancer	0.00119	0.00463	CbGpPWpGaD
Micafungin—ARSA—Metabolism—GSTA1—liver cancer	0.00118	0.00462	CbGpPWpGaD
Micafungin—ARSA—Metabolism—NAT2—liver cancer	0.00117	0.00456	CbGpPWpGaD
Micafungin—Erythema multiforme—Epirubicin—liver cancer	0.00116	0.00156	CcSEcCtD
Micafungin—Bradycardia—Doxorubicin—liver cancer	0.00116	0.00156	CcSEcCtD
Micafungin—Flushing—Epirubicin—liver cancer	0.00114	0.00153	CcSEcCtD
Micafungin—Cardiac disorder—Epirubicin—liver cancer	0.00114	0.00153	CcSEcCtD
Micafungin—Hepatitis—Doxorubicin—liver cancer	0.00114	0.00153	CcSEcCtD
Micafungin—ARSA—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.00112	0.00439	CbGpPWpGaD
Micafungin—Urinary tract disorder—Doxorubicin—liver cancer	0.00112	0.00151	CcSEcCtD
Micafungin—ARSA—Metabolism—ALDOB—liver cancer	0.00112	0.00438	CbGpPWpGaD
Micafungin—Oedema peripheral—Doxorubicin—liver cancer	0.00112	0.00151	CcSEcCtD
Micafungin—Connective tissue disorder—Doxorubicin—liver cancer	0.00112	0.0015	CcSEcCtD
Micafungin—Angiopathy—Epirubicin—liver cancer	0.00111	0.0015	CcSEcCtD
Micafungin—Urethral disorder—Doxorubicin—liver cancer	0.00111	0.0015	CcSEcCtD
Micafungin—Immune system disorder—Epirubicin—liver cancer	0.00111	0.00149	CcSEcCtD
Micafungin—Mediastinal disorder—Epirubicin—liver cancer	0.00111	0.00149	CcSEcCtD
Micafungin—Chills—Epirubicin—liver cancer	0.0011	0.00148	CcSEcCtD
Micafungin—Arrhythmia—Epirubicin—liver cancer	0.0011	0.00148	CcSEcCtD
Micafungin—Mental disorder—Epirubicin—liver cancer	0.00108	0.00145	CcSEcCtD
Micafungin—Erythema multiforme—Doxorubicin—liver cancer	0.00108	0.00145	CcSEcCtD
Micafungin—Erythema—Epirubicin—liver cancer	0.00107	0.00144	CcSEcCtD
Micafungin—Malnutrition—Epirubicin—liver cancer	0.00107	0.00144	CcSEcCtD
Micafungin—ARSA—Metabolism—CRABP1—liver cancer	0.00107	0.00417	CbGpPWpGaD
Micafungin—Flushing—Doxorubicin—liver cancer	0.00106	0.00142	CcSEcCtD
Micafungin—Cardiac disorder—Doxorubicin—liver cancer	0.00106	0.00142	CcSEcCtD
Micafungin—Dysgeusia—Epirubicin—liver cancer	0.00105	0.00141	CcSEcCtD
Micafungin—Back pain—Epirubicin—liver cancer	0.00103	0.00139	CcSEcCtD
Micafungin—Angiopathy—Doxorubicin—liver cancer	0.00103	0.00139	CcSEcCtD
Micafungin—Immune system disorder—Doxorubicin—liver cancer	0.00103	0.00138	CcSEcCtD
Micafungin—Mediastinal disorder—Doxorubicin—liver cancer	0.00102	0.00138	CcSEcCtD
Micafungin—Chills—Doxorubicin—liver cancer	0.00102	0.00137	CcSEcCtD
Micafungin—Arrhythmia—Doxorubicin—liver cancer	0.00102	0.00137	CcSEcCtD
Micafungin—COMT—Metabolism—UGDH—liver cancer	0.00101	0.00392	CbGpPWpGaD
Micafungin—Mental disorder—Doxorubicin—liver cancer	0.000996	0.00134	CcSEcCtD
Micafungin—Erythema—Doxorubicin—liver cancer	0.00099	0.00133	CcSEcCtD
Micafungin—Malnutrition—Doxorubicin—liver cancer	0.00099	0.00133	CcSEcCtD
Micafungin—Anaemia—Epirubicin—liver cancer	0.000989	0.00133	CcSEcCtD
Micafungin—Dysgeusia—Doxorubicin—liver cancer	0.000969	0.0013	CcSEcCtD
Micafungin—ARSA—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000963	0.00376	CbGpPWpGaD
Micafungin—Leukopenia—Epirubicin—liver cancer	0.000958	0.00129	CcSEcCtD
Micafungin—Back pain—Doxorubicin—liver cancer	0.000957	0.00129	CcSEcCtD
Micafungin—COMT—Metabolism—EPT1—liver cancer	0.000946	0.00369	CbGpPWpGaD
Micafungin—Palpitations—Epirubicin—liver cancer	0.000945	0.00127	CcSEcCtD
Micafungin—ARSA—Metabolism—HPGDS—liver cancer	0.000935	0.00365	CbGpPWpGaD
Micafungin—Cough—Epirubicin—liver cancer	0.000933	0.00126	CcSEcCtD
Micafungin—ARSA—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000929	0.00363	CbGpPWpGaD
Micafungin—Convulsion—Epirubicin—liver cancer	0.000927	0.00125	CcSEcCtD
Micafungin—Hypertension—Epirubicin—liver cancer	0.000924	0.00124	CcSEcCtD
Micafungin—Anaemia—Doxorubicin—liver cancer	0.000915	0.00123	CcSEcCtD
Micafungin—Arthralgia—Epirubicin—liver cancer	0.000911	0.00122	CcSEcCtD
Micafungin—Anxiety—Epirubicin—liver cancer	0.000908	0.00122	CcSEcCtD
Micafungin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000904	0.00122	CcSEcCtD
Micafungin—COMT—Metabolism—TAT—liver cancer	0.000896	0.0035	CbGpPWpGaD
Micafungin—Leukopenia—Doxorubicin—liver cancer	0.000886	0.00119	CcSEcCtD
Micafungin—Confusional state—Epirubicin—liver cancer	0.00088	0.00118	CcSEcCtD
Micafungin—COMT—Transmission across Chemical Synapses—BRAF—liver cancer	0.000877	0.00342	CbGpPWpGaD
Micafungin—Palpitations—Doxorubicin—liver cancer	0.000875	0.00118	CcSEcCtD
Micafungin—Anaphylactic shock—Epirubicin—liver cancer	0.000873	0.00117	CcSEcCtD
Micafungin—ARSA—Metabolism of proteins—F2—liver cancer	0.00087	0.00339	CbGpPWpGaD
Micafungin—Infection—Epirubicin—liver cancer	0.000867	0.00117	CcSEcCtD
Micafungin—Cough—Doxorubicin—liver cancer	0.000864	0.00116	CcSEcCtD
Micafungin—Shock—Epirubicin—liver cancer	0.000859	0.00115	CcSEcCtD
Micafungin—Convulsion—Doxorubicin—liver cancer	0.000858	0.00115	CcSEcCtD
Micafungin—Nervous system disorder—Epirubicin—liver cancer	0.000856	0.00115	CcSEcCtD
Micafungin—Thrombocytopenia—Epirubicin—liver cancer	0.000855	0.00115	CcSEcCtD
Micafungin—Hypertension—Doxorubicin—liver cancer	0.000855	0.00115	CcSEcCtD
Micafungin—Tachycardia—Epirubicin—liver cancer	0.000852	0.00115	CcSEcCtD
Micafungin—Skin disorder—Epirubicin—liver cancer	0.000848	0.00114	CcSEcCtD
Micafungin—ARSA—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000847	0.0033	CbGpPWpGaD
Micafungin—Hyperhidrosis—Epirubicin—liver cancer	0.000844	0.00113	CcSEcCtD
Micafungin—Arthralgia—Doxorubicin—liver cancer	0.000843	0.00113	CcSEcCtD
Micafungin—Anxiety—Doxorubicin—liver cancer	0.00084	0.00113	CcSEcCtD
Micafungin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000837	0.00113	CcSEcCtD
Micafungin—ARSA—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000836	0.00326	CbGpPWpGaD
Micafungin—ARSA—Metabolism—PSMD10—liver cancer	0.000833	0.00325	CbGpPWpGaD
Micafungin—ARSA—Metabolism—PSMA4—liver cancer	0.000833	0.00325	CbGpPWpGaD
Micafungin—Anorexia—Epirubicin—liver cancer	0.000832	0.00112	CcSEcCtD
Micafungin—Hypotension—Epirubicin—liver cancer	0.000816	0.0011	CcSEcCtD
Micafungin—Confusional state—Doxorubicin—liver cancer	0.000815	0.0011	CcSEcCtD
Micafungin—ARSA—Metabolism—GOT2—liver cancer	0.000811	0.00316	CbGpPWpGaD
Micafungin—Anaphylactic shock—Doxorubicin—liver cancer	0.000808	0.00109	CcSEcCtD
Micafungin—Infection—Doxorubicin—liver cancer	0.000803	0.00108	CcSEcCtD
Micafungin—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000795	0.00107	CcSEcCtD
Micafungin—Shock—Doxorubicin—liver cancer	0.000795	0.00107	CcSEcCtD
Micafungin—Nervous system disorder—Doxorubicin—liver cancer	0.000792	0.00107	CcSEcCtD
Micafungin—Thrombocytopenia—Doxorubicin—liver cancer	0.000791	0.00106	CcSEcCtD
Micafungin—Insomnia—Epirubicin—liver cancer	0.00079	0.00106	CcSEcCtD
Micafungin—Tachycardia—Doxorubicin—liver cancer	0.000788	0.00106	CcSEcCtD
Micafungin—Skin disorder—Doxorubicin—liver cancer	0.000785	0.00105	CcSEcCtD
Micafungin—Hyperhidrosis—Doxorubicin—liver cancer	0.000781	0.00105	CcSEcCtD
Micafungin—Dyspnoea—Epirubicin—liver cancer	0.000778	0.00105	CcSEcCtD
Micafungin—Somnolence—Epirubicin—liver cancer	0.000776	0.00104	CcSEcCtD
Micafungin—Anorexia—Doxorubicin—liver cancer	0.00077	0.00104	CcSEcCtD
Micafungin—Dyspepsia—Epirubicin—liver cancer	0.000768	0.00103	CcSEcCtD
Micafungin—ARSA—Metabolism—CYP2E1—liver cancer	0.000762	0.00297	CbGpPWpGaD
Micafungin—Decreased appetite—Epirubicin—liver cancer	0.000759	0.00102	CcSEcCtD
Micafungin—Hypotension—Doxorubicin—liver cancer	0.000755	0.00101	CcSEcCtD
Micafungin—Gastrointestinal disorder—Epirubicin—liver cancer	0.000754	0.00101	CcSEcCtD
Micafungin—Fatigue—Epirubicin—liver cancer	0.000753	0.00101	CcSEcCtD
Micafungin—Constipation—Epirubicin—liver cancer	0.000747	0.001	CcSEcCtD
Micafungin—ARSA—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000738	0.00288	CbGpPWpGaD
Micafungin—ARSA—Metabolism of proteins—MMP2—liver cancer	0.000737	0.00288	CbGpPWpGaD
Micafungin—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000736	0.00099	CcSEcCtD
Micafungin—COMT—Transmission across Chemical Synapses—RAF1—liver cancer	0.000733	0.00286	CbGpPWpGaD
Micafungin—Insomnia—Doxorubicin—liver cancer	0.000731	0.000982	CcSEcCtD
Micafungin—Dyspnoea—Doxorubicin—liver cancer	0.00072	0.000968	CcSEcCtD
Micafungin—Feeling abnormal—Epirubicin—liver cancer	0.000719	0.000967	CcSEcCtD
Micafungin—Somnolence—Doxorubicin—liver cancer	0.000718	0.000966	CcSEcCtD
Micafungin—Gastrointestinal pain—Epirubicin—liver cancer	0.000714	0.00096	CcSEcCtD
Micafungin—ARSA—Metabolism—CYCS—liver cancer	0.000713	0.00278	CbGpPWpGaD
Micafungin—Dyspepsia—Doxorubicin—liver cancer	0.000711	0.000956	CcSEcCtD
Micafungin—Decreased appetite—Doxorubicin—liver cancer	0.000702	0.000944	CcSEcCtD
Micafungin—ARSA—Metabolism—GOT1—liver cancer	0.0007	0.00273	CbGpPWpGaD
Micafungin—ARSA—Metabolism—GGT1—liver cancer	0.0007	0.00273	CbGpPWpGaD
Micafungin—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000697	0.000938	CcSEcCtD
Micafungin—Fatigue—Doxorubicin—liver cancer	0.000696	0.000936	CcSEcCtD
Micafungin—Urticaria—Epirubicin—liver cancer	0.000694	0.000932	CcSEcCtD
Micafungin—Constipation—Doxorubicin—liver cancer	0.000691	0.000929	CcSEcCtD
Micafungin—Abdominal pain—Epirubicin—liver cancer	0.00069	0.000928	CcSEcCtD
Micafungin—Body temperature increased—Epirubicin—liver cancer	0.00069	0.000928	CcSEcCtD
Micafungin—COMT—Neuronal System—BRAF—liver cancer	0.000672	0.00262	CbGpPWpGaD
Micafungin—Feeling abnormal—Doxorubicin—liver cancer	0.000666	0.000895	CcSEcCtD
Micafungin—Gastrointestinal pain—Doxorubicin—liver cancer	0.000661	0.000888	CcSEcCtD
Micafungin—Hypersensitivity—Epirubicin—liver cancer	0.000643	0.000865	CcSEcCtD
Micafungin—Urticaria—Doxorubicin—liver cancer	0.000642	0.000863	CcSEcCtD
Micafungin—Abdominal pain—Doxorubicin—liver cancer	0.000639	0.000859	CcSEcCtD
Micafungin—Body temperature increased—Doxorubicin—liver cancer	0.000639	0.000859	CcSEcCtD
Micafungin—ARSA—Metabolism—GSTP1—liver cancer	0.000629	0.00245	CbGpPWpGaD
Micafungin—Asthenia—Epirubicin—liver cancer	0.000626	0.000842	CcSEcCtD
Micafungin—ARSA—Metabolism—HMOX1—liver cancer	0.00062	0.00242	CbGpPWpGaD
Micafungin—Pruritus—Epirubicin—liver cancer	0.000618	0.00083	CcSEcCtD
Micafungin—COMT—Metabolism—CPT1B—liver cancer	0.000609	0.00238	CbGpPWpGaD
Micafungin—COMT—Metabolism—GLUL—liver cancer	0.000609	0.00238	CbGpPWpGaD
Micafungin—Diarrhoea—Epirubicin—liver cancer	0.000597	0.000803	CcSEcCtD
Micafungin—Hypersensitivity—Doxorubicin—liver cancer	0.000595	0.0008	CcSEcCtD
Micafungin—COMT—Metabolism—NR1H4—liver cancer	0.000588	0.00229	CbGpPWpGaD
Micafungin—Asthenia—Doxorubicin—liver cancer	0.00058	0.000779	CcSEcCtD
Micafungin—ARSA—Metabolism—GSTM1—liver cancer	0.000578	0.00225	CbGpPWpGaD
Micafungin—COMT—Metabolism—GSTA3—liver cancer	0.000578	0.00225	CbGpPWpGaD
Micafungin—Dizziness—Epirubicin—liver cancer	0.000577	0.000776	CcSEcCtD
Micafungin—Pruritus—Doxorubicin—liver cancer	0.000572	0.000768	CcSEcCtD
Micafungin—ARSA—Metabolism of proteins—CTNNB1—liver cancer	0.000565	0.00221	CbGpPWpGaD
Micafungin—COMT—Neuronal System—RAF1—liver cancer	0.000561	0.00219	CbGpPWpGaD
Micafungin—Vomiting—Epirubicin—liver cancer	0.000555	0.000746	CcSEcCtD
Micafungin—Diarrhoea—Doxorubicin—liver cancer	0.000553	0.000743	CcSEcCtD
Micafungin—Rash—Epirubicin—liver cancer	0.00055	0.00074	CcSEcCtD
Micafungin—Dermatitis—Epirubicin—liver cancer	0.00055	0.000739	CcSEcCtD
Micafungin—ARSA—Metabolism—CYP1A1—liver cancer	0.000548	0.00214	CbGpPWpGaD
Micafungin—Headache—Epirubicin—liver cancer	0.000547	0.000735	CcSEcCtD
Micafungin—Dizziness—Doxorubicin—liver cancer	0.000534	0.000718	CcSEcCtD
Micafungin—COMT—Metabolism—GSTA4—liver cancer	0.000528	0.00206	CbGpPWpGaD
Micafungin—Nausea—Epirubicin—liver cancer	0.000519	0.000697	CcSEcCtD
Micafungin—COMT—Metabolism—GSTA2—liver cancer	0.000515	0.00201	CbGpPWpGaD
Micafungin—Vomiting—Doxorubicin—liver cancer	0.000514	0.000691	CcSEcCtD
Micafungin—ARSA—Metabolism—MTHFR—liver cancer	0.00051	0.00199	CbGpPWpGaD
Micafungin—Rash—Doxorubicin—liver cancer	0.000509	0.000685	CcSEcCtD
Micafungin—Dermatitis—Doxorubicin—liver cancer	0.000509	0.000684	CcSEcCtD
Micafungin—Headache—Doxorubicin—liver cancer	0.000506	0.00068	CcSEcCtD
Micafungin—ARSA—Metabolism—PPARA—liver cancer	0.000501	0.00195	CbGpPWpGaD
Micafungin—COMT—Metabolism—GSTA1—liver cancer	0.000497	0.00194	CbGpPWpGaD
Micafungin—COMT—Metabolism—NAT2—liver cancer	0.000491	0.00192	CbGpPWpGaD
Micafungin—Nausea—Doxorubicin—liver cancer	0.00048	0.000645	CcSEcCtD
Micafungin—COMT—Metabolism—ALDOB—liver cancer	0.000471	0.00184	CbGpPWpGaD
Micafungin—ARSA—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.00045	0.00176	CbGpPWpGaD
Micafungin—COMT—Metabolism—CRABP1—liver cancer	0.000449	0.00175	CbGpPWpGaD
Micafungin—ARSA—Metabolism—PIK3CG—liver cancer	0.000429	0.00167	CbGpPWpGaD
Micafungin—ARSA—Metabolism—PPARG—liver cancer	0.000414	0.00162	CbGpPWpGaD
Micafungin—COMT—Transmission across Chemical Synapses—HRAS—liver cancer	0.000403	0.00157	CbGpPWpGaD
Micafungin—COMT—Metabolism—HPGDS—liver cancer	0.000393	0.00153	CbGpPWpGaD
Micafungin—ARSA—Metabolism—PIK3CD—liver cancer	0.000377	0.00147	CbGpPWpGaD
Micafungin—ARSA—Metabolism—ALB—liver cancer	0.000372	0.00145	CbGpPWpGaD
Micafungin—COMT—Metabolism—PSMA4—liver cancer	0.00035	0.00137	CbGpPWpGaD
Micafungin—COMT—Metabolism—PSMD10—liver cancer	0.00035	0.00137	CbGpPWpGaD
Micafungin—COMT—Metabolism—GOT2—liver cancer	0.00034	0.00133	CbGpPWpGaD
Micafungin—ARSA—Metabolism—PIK3CB—liver cancer	0.000329	0.00128	CbGpPWpGaD
Micafungin—COMT—Metabolism—CYP2E1—liver cancer	0.00032	0.00125	CbGpPWpGaD
Micafungin—COMT—Neuronal System—HRAS—liver cancer	0.000309	0.00121	CbGpPWpGaD
Micafungin—COMT—Metabolism—CYCS—liver cancer	0.000299	0.00117	CbGpPWpGaD
Micafungin—COMT—Metabolism—GOT1—liver cancer	0.000294	0.00115	CbGpPWpGaD
Micafungin—COMT—Metabolism—GGT1—liver cancer	0.000294	0.00115	CbGpPWpGaD
Micafungin—COMT—Metabolism—GSTP1—liver cancer	0.000264	0.00103	CbGpPWpGaD
Micafungin—COMT—Metabolism—HMOX1—liver cancer	0.00026	0.00102	CbGpPWpGaD
Micafungin—COMT—Metabolism—GSTM1—liver cancer	0.000243	0.000947	CbGpPWpGaD
Micafungin—COMT—Metabolism—CYP1A1—liver cancer	0.00023	0.000897	CbGpPWpGaD
Micafungin—COMT—Metabolism—MTHFR—liver cancer	0.000214	0.000837	CbGpPWpGaD
Micafungin—COMT—Metabolism—PPARA—liver cancer	0.00021	0.000821	CbGpPWpGaD
Micafungin—ARSA—Metabolism—PIK3CA—liver cancer	0.0002	0.000782	CbGpPWpGaD
Micafungin—COMT—Metabolism—PIK3CG—liver cancer	0.00018	0.000703	CbGpPWpGaD
Micafungin—COMT—Metabolism—PPARG—liver cancer	0.000174	0.000678	CbGpPWpGaD
Micafungin—ARSA—Metabolism—AKT1—liver cancer	0.000164	0.000639	CbGpPWpGaD
Micafungin—COMT—Metabolism—PIK3CD—liver cancer	0.000158	0.000618	CbGpPWpGaD
Micafungin—COMT—Metabolism—ALB—liver cancer	0.000156	0.00061	CbGpPWpGaD
Micafungin—COMT—Metabolism—PIK3CB—liver cancer	0.000138	0.000539	CbGpPWpGaD
Micafungin—COMT—Metabolism—PIK3CA—liver cancer	8.41e-05	0.000328	CbGpPWpGaD
Micafungin—COMT—Metabolism—AKT1—liver cancer	6.87e-05	0.000268	CbGpPWpGaD
